✦ LIBER ✦

Effects of vertical HIV infection on the persistence of anti-HBs after a schedule of three doses of recombinant hepatitis B vaccine

✍ Scribed by Sérgio Júlio Fernandes; Natasha Slhessarenko; Francisco José Dutra Souto

Book ID: 116960282
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 308 KB
Volume: 26
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2007.12.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PERSISTENCE OF ANTI-HBs AFTER INTRADERMA

PERSISTENCE OF ANTI-HBs AFTER INTRADERMAL INOCULATION OF REDUCED DOSES OF HEPATITIS B VACCINE

✍ Zoulek, Gert; Lorbeer, Bernd; Jilg, Wolfgang; Deinhardt, Friedrich 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 321 KB

Long-term persistence of anti-HBs after

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

✍ Koen Van Herck; Pierre Van Damme; Stefan Thoelen; André Meheus 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Increasing the number of hepatitis B vac

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

✍ David Rey; Véronique Krantz; Marialuisa Partisani; Marie-Paule Schmitt; Pierre M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Response to a booster dose 18 months aft

Response to a booster dose 18 months after a low anti-HBs response (10–99 IU/l) to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine

✍ J. Struve; Ola Weiland; Marianne Fosgren; B. Aronsson; B. Frenning 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 686 KB

Antibody persistence and immune memory i

Antibody persistence and immune memory in adults, 15 years after a three-dose schedule of a combined hepatitis A and B vaccine

✍ P. Van Damme; G. Leroux-Roels; P. Crasta; M. Messier; J-M. Jacquet; K. Van Herck 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Abstract A combined hepatitis A and B vaccine is available since 1996. Two separate open‐label primary studies evaluated the immunogenicity and safety of this hepatitis A and B vaccine (720 EI.U of HAV and 20 µg of HBsAg) in 306 healthy subjects aged 17–43 years who received three doses of the v

Effects of different dose levels and vac

Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients

✍ M. Bruguera; J.L. Rodicio; J.M. Alcazar; A. Oliver; G. Del Rio; R. Esteban-Mur 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 312 KB